Allt inom mfn-ext-nq
Nanexa named as finalist in Fierce Innovation Awards Life Sciences Edition 2025
Nanexa, is pleased to announce that the company has been selected as a finalist in the Drug Delivery Technology category by the renowned industry publication Fierce Life Sciences. The annual Fierce Life Sciences Innovation Awards identify and showcase outstanding innovation that is driving improvements in life science technologies. Their panel of expert judges has identified Nanexa as a company whose pioneering solutions have the potential to create efficiencies, engage patients, or revolutionize the pharmaceutical industry.
Nanexa AB changes Certified Adviser to Tapper Partners AB
Nanexa AB announces today that the company is changing its Certified Adviser to Tapper Partners AB.